Skip navigation

Enhance Value Propositions and Evidence Generation for Coverage and Coding Payments

March 16-17, 2016
  • Chicago, IL

CBI’s Medical Device Reimbursement & Access Summit provides an excellent opportunity to discover not only how to survive, but to thrive in the changing reimbursement landscape. With an increase in demand for value-based evidence, it is becoming more crucial than ever for industry professionals to understand the coverage and coding requirements to ensure reimbursement and market access for medical products.

Special
Addresses
From:

James Rollins, M.D.
Director, Division of Medical
and Surgical Services, Coverage
and Analysis Group, CMS

Van Crocker
President
Healthagen Outcomes,
A Division of Aetna

Strategies to Thrive in an Ever-Changing Reimbursement Landscape:

  • Identify necessary components to demonstrate value and secure adequate reimbursement
  • Sharpen understandings of the RUC Process (stage 2) and why getting a new code priced is often harder than obtaining the initial code
  • Navigate how, and when, to engage with payers, particularly when introducing a new product to market
  • Uncover the payment process for physicians when there is no coverage
  • Align sales, marketing and clinical publication planning to reinforce your product’s ‘real value’ in this new value-based world
  • Expand the role of reimbursement/market access to successfully navigate today’s Value Analysis Committees (VACs)
  • Find interim solutions when widespread coverage is not immediately attained

Featured Industry Perspectives Include:

CHAIRMAN Scott Tackett
Head Global Market Access
Intuitive Surgical

Betsy Gross, RN, BSN, CPC, CENTC
Vice President, Healthcare Economics
and Reimbursement
Intersect ENT

Steve Phillips
Senior Director, Global Health Policy,
Worldwide Government Affairs and Policy
Johnson & Johnson

Jayne A. Little
Vice President, Global Health Economics and Reimbursement
Halt Medical, Inc.

Ann Thompson
Senior Director,
Health Economics and Reimbursement
Edwards Lifesciences

Maria Koullick
Senior Director of Healthcare Economics
St. Jude Medical

Previous Attendee Acclaim:

March 16-17, 2016 The James Chicago, IL

Medical Device Reimbursement & Access Summit

Enhance Value Propositions and Evidence Generation for Coverage and Coding Payments

CBI’s Medical Device Reimbursement & Access Summit provides an excellent opportunity to discover not only how to survive, but to thrive in the changing reimbursement landscape. With an increase in demand for value-based evidence, it is becoming more crucial than ever for industry professionals to understand the coverage and coding requirements to ensure reimbursement and market access for medical products.

Special
Addresses
From:

James Rollins, M.D.
Director, Division of Medical
and Surgical Services, Coverage
and Analysis Group, CMS

Van Crocker
President
Healthagen Outcomes,
A Division of Aetna

Strategies to Thrive in an Ever-Changing Reimbursement Landscape:

  • Identify necessary components to demonstrate value and secure adequate reimbursement
  • Sharpen understandings of the RUC Process (stage 2) and why getting a new code priced is often harder than obtaining the initial code
  • Navigate how, and when, to engage with payers, particularly when introducing a new product to market
  • Uncover the payment process for physicians when there is no coverage
  • Align sales, marketing and clinical publication planning to reinforce your product’s ‘real value’ in this new value-based world
  • Expand the role of reimbursement/market access to successfully navigate today’s Value Analysis Committees (VACs)
  • Find interim solutions when widespread coverage is not immediately attained

Featured Industry Perspectives Include:

CHAIRMAN Scott Tackett
Head Global Market Access
Intuitive Surgical

Betsy Gross, RN, BSN, CPC, CENTC
Vice President, Healthcare Economics
and Reimbursement
Intersect ENT

Steve Phillips
Senior Director, Global Health Policy,
Worldwide Government Affairs and Policy
Johnson & Johnson

Jayne A. Little
Vice President, Global Health Economics and Reimbursement
Halt Medical, Inc.

Ann Thompson
Senior Director,
Health Economics and Reimbursement
Edwards Lifesciences

Maria Koullick
Senior Director of Healthcare Economics
St. Jude Medical

Previous Attendee Acclaim:

March 16-17, 2016 The James Chicago, IL